Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients

Main Article Content

Olusayo Louise- Oluwasanmi


The symptoms of COVID-19, leading to pulmonary edema and the need for ventilators may be due to the fact that the virus increases bradykinin levels. If true, administering bradykinin blockers can provide a cheap way to reduce the severity of the symptoms and the burden on hospital resources, and, ultimately, the fatality rate.

ACEIs, positive feedback, pulmonary edema.

Article Details

How to Cite
Oluwasanmi, O. L.-. (2020). Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients. Journal of Advances in Medicine and Medical Research, 32(12), 1-4. https://doi.org/10.9734/jammr/2020/v32i1230537
Short Communication


Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Tai Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Medicine. 2020;8:420–22.

Diaz JH. Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. Journal of Travel Medicine. 2020;27(3):1-2.

Biebuyck JF, Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down Regulation of Skeletal Muscle Acetylcholine Receptors Effects on Neuromuscular Blockers. Anesthesiology: The Journal of the American Society of Anesthesiologists. 1992;76(5):822-843.

Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. American Review of Respiratory Disease. 1988;137(3):613-616.

Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Ibuprofen augments bradykinin-induced glycoconjugate secretion by human nasal mucosa in vivo. Journal of Allergy and Clinical Immuno-logy. 1992;89(5):1032-1039.

Fuller RW, Dixon CM, Cuss FM, Barnes PJ. Bradykinin-induced bronchoconstriction in humans: Mode of action. American Review of Respiratory Disease. 1987;135(1):176-180.

Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. New England Journal of Medicine. 2002;347(8): 621-622.

Hao Y, Okamura S, Wang LM, Mineshita S. The involvement of bradykinin in adrenaline-induced pulmonary edema in rats. Journal of Medical and Dental Sciences. 2001;48(3):79–85.

Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I. Diagnosis and treatment of Bradykinin-mediated Angioedema: Outcomes from an angioedema expert consensus meeting. International Archives of Allergy and Immunology 2014;165(2):119-127.

Day M. Covid-19: Ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368: 1086.

Folkerts G, Vilieger JWD, de Vries, ANNICK, Faas S, van der Linde HENK, Engels F, Nijkamp FP. Virus-and bradykinin-induced airway hyperrespon-siveness in guinea pigs. American Journal of Respiratory and Critical Care Medicine. 2000;161(5):1666-1671.